Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador - Report - MDSpire
Advertisement
Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador
Barriers and Variations in Cancer Diagnosis in Latin America
Overview
This study analyzes the diagnostic pathways and provider intervals for cancer patients in public health systems of Chile, Colombia, and Ecuador. It highlights significant delays in diagnosis, particularly within the provider interval, which are critical to understanding cancer mortality rates in the region.
Background
Delays in cancer diagnosis and treatment are a major contributor to rising mortality rates in Latin America. The provider interval, which is often longer than the patient interval, reveals systemic inefficiencies that differ from those observed in high-income countries. Understanding these barriers is essential for improving cancer care and outcomes in these fragmented healthcare systems.
Data Highlights
Remove placeholder text and replace with relevant findings or data points from the study.
Key Findings
Provider intervals for breast cancer diagnosis range from 60 to 195 days, significantly longer than patient intervals of 10 to 30 days.
Diagnostic pathways in Latin America are complex and differ from those in high-income countries, often lacking a clear starting point.
Limited access to secondary care and poor coordination across healthcare levels contribute to diagnostic delays.
Existing studies on provider intervals primarily focus on breast cancer, with limited research on other cancer types in the region.
Integrated care strategies and maximum waiting times have been implemented but show limited effectiveness in reducing diagnostic delays.
Clinical Implications
Healthcare providers should be aware of the significant delays in cancer diagnosis within public health systems in Latin America. Strategies to streamline diagnostic pathways and improve coordination between care levels are essential for enhancing patient outcomes.
Conclusion
Addressing the barriers to timely cancer diagnosis in Latin America is crucial for reducing mortality rates. Continued research and implementation of effective healthcare strategies are necessary to improve patient care in these regions.
by María-Luisa Vázquez, Pamela Eguiguren, Amparo-Susana Mogollón-Pérez, Andrés Peralta, Josep M Borràs, Ignacio Aznar-Lou, Signe Smith Jervelund, Carol Cardozo, Samar Benthami-Zarhouni, Iván Dueñas-Espín, María Luisa Garmendia, Sónia Dias, Ingrid Vargas